SRx Health adds Sammy Dorf to board; $300M financing track record

SRx Health Solutions (SRXH) appointed Sammy Dorf to its Board of Directors, effective immediately.

Rhea-AI Filing Summary

SRx Health Solutions (SRXH) appointed Sammy Dorf to its Board of Directors, effective immediately. Dorf is Executive Chairman of Flora Growth and previously co-founded Verano Holdings, a multi-state cannabis company. The filing highlights his capital markets and operational experience, noting he has raised over $300 million and helped secure 25+ licenses across 14 states. The company also furnished a related press release as an exhibit.

Insights

Corporate Governance Analyst

Board adds an experienced operator and fundraiser; governance impact appears incremental rather than transformative.

SRx Health Solutions appointed Sammy Dorf to its Board effective November 10, 2025. He will serve until a successor is elected or he resigns or is removed. The filing also includes Exhibit 99.1, a press release dated the same day.

Dorf’s background includes Executive Chairman of Flora Growth Corp. and Co‑Founder/Chief Growth Officer of Verano Holdings. The biography highlights experience raising over $300 million, securing 25+ licenses across 14 states, and work in cryptocurrency investments, treasury management, and alternative asset strategy.

What it means: a new director with capital formation and multi‑state operating experience joins the board. Why it matters: such experience can strengthen oversight and capital planning. Near term, watch any committee assignments and whether subsequent filings reference operational or financing initiatives tied to this governance change over the next two quarters.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SRXH announce in this 8-K?

SRx Health Solutions appointed Sammy Dorf to its Board of Directors, effective immediately.

What is Sammy Dorf’s current role outside SRXH?

He serves as the Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC).

What relevant experience does Sammy Dorf bring to SRXH?

He co-founded Verano Holdings and, per the filing, has raised over $300 million and secured 25+ licenses across 14 states.

How long will Sammy Dorf serve on SRXH’s board?

He will serve until a successor is elected and qualified, or until his resignation or removal.

Was any additional material provided with the announcement?

Yes. The company included a press release as Exhibit 99.1.

What exchange does SRXH trade on and under what symbol?

SRXH trades on the NYSE American under the symbol SRXH.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/10/2025 - 01:14 PM Learn about SEC filing dates

false 0001471727 0001471727 2025-11-10 2025-11-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 10, 2025

SRx Health Solutions, Inc.

(Exact name of Registrant as Specified in its Charter)

Delaware		001-40477		83-4284557
(State or other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

12400 Race Track Road

Tampa, Florida 33626

(Address of Principal Executive Offices) (Zip Code) 

(Registrant’s Telephone Number, Including Area Code): (212) 896-1254

N/A

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value share		SRXH		NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Sammy Dorf as a Director

On November 10, 2025, the Board of Directors (the “Board”) of SRx Health Solutions, Inc., a Delaware corporation (the “Company”) appointed Sammy Dorf, Esq. as a director of the Company, effective immediately, to serve in such capacity until a successor has been elected and qualified, or until his resignation or removal.

Mr. Dorf currently serves as the Executive Chairman of Flora Growth Corp. (NASDAQ: FLGC). Prior to joining Flora, Sammy was the Co-Founder and Chief Growth Officer of Verano Holdings, one of the most successful multi-state cannabis companies in the United States, from 2015 to 2021. At Verano, Mr. Dorf was instrumental in the company’s evolution from a start-up into a national powerhouse known for its premium products, operational sophistication, and award-winning brands.. To date, Mr. Dorf has successfully raised over $300 million in capital and secured 25+ licenses across 14 states. Beyond the cannabis sector, Sammy has also demonstrated deep expertise in cryptocurrency investments, treasury management, and alternative asset strategy, helping companies optimize liquidity, hedge exposure, and build resilient portfolios in emerging financial ecosystems.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release, dated November 10, 2025.
104		Cover Page Interactive Data File (Embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SRx Health Solutions, Inc.
	By:	/s/ Carolina Martinez
	Name:	Carolina Martinez
	Title:	Chief Financial Officer

November 10, 2025